Compare NGNE & HNST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NGNE | HNST |
|---|---|---|
| Founded | 2003 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Catalog/Specialty Distribution |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 327.8M | 303.0M |
| IPO Year | N/A | 2021 |
| Metric | NGNE | HNST |
|---|---|---|
| Price | $20.61 | $2.64 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 2 |
| Target Price | ★ $38.50 | $3.00 |
| AVG Volume (30 Days) | 188.3K | ★ 2.1M |
| Earning Date | 11-13-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.06 |
| Revenue | N/A | ★ $383,117,000.00 |
| Revenue This Year | N/A | $0.03 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $42.43 |
| Revenue Growth | N/A | ★ 3.89 |
| 52 Week Low | $6.88 | $2.31 |
| 52 Week High | $37.27 | $7.13 |
| Indicator | NGNE | HNST |
|---|---|---|
| Relative Strength Index (RSI) | 47.11 | 41.83 |
| Support Level | $19.28 | $2.57 |
| Resistance Level | $22.99 | $2.76 |
| Average True Range (ATR) | 1.44 | 0.11 |
| MACD | 0.32 | -0.01 |
| Stochastic Oscillator | 40.15 | 17.07 |
Neurogene Inc is a clinical-stage biotechnology company committed to overcoming the limitations of neurological diseases into treatable conditions, by harnessing its proprietary transgene regulation technology, EXACTTM (Expression Attenuation via Construct Tuning). It is building a differentiated product portfolio of genetic medicines for rare neurological diseases with high unmet needs. The drug candidates in the company's product pipeline include NGN-401, which is in development for the treatment of Rett syndrome, using its EXACT platform, and NGN-101, a non-EXACT, conventional gene therapy development candidate for the treatment of CLN5 Batten disease, designed to deliver the CLN5 gene and packaged in an AAV9 capsid.
The Honest Co Inc is a digitally-native consumer products company to makes purpose-driven consumer products designed for all people. It is an omnichannel brand, ensuring its products are available wherever its consumers shop through the company's Retail and Digital channels. It has three product categories namely; Diapers and Wipes, Skin and Personal Care, and Household and Wellness, out of which the majority of its revenue is generated from the sale of diapers and wipes. The company operates only in the United States.